Companies Dominating the Fentanyl Landscape
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Boehringer Ingelheim GmbH
- Bayer AG
- Novartis AG
- Sanofi-aventis Groupe
- Abbott Laboratories
- Merck & Co., Inc.
- Validus Pharmaceuticals LLC
- Teva Pharmaceutical Industries Ltd.
- Siemens Healthcare GmbH
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Fentanyl Market in 2025 is evaluated at USD 17.92 billion.
The global market size surpassed USD 17.02 billion in 2024 and is projected to witness a CAGR of over 6.6%, crossing USD 39.07 billion revenue by 2037.
North America is poised to cross USD 13.67 billion by 2037, fueled by growing population, research activity, and the increasing affordability of advanced cancer treatments in North America.
The major players in the market include Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Bayer AG, Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Validus Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., Siemens Healthcare GmbH.
